Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

MK-0343 has different effects on healthy volunteers than lorazepam

Feb. 26, 2008

Allon Therapeutics adds Alzheimer's patients to ongoing phase II clinical trial of AL-108

Feb. 25, 2008

Novel 5-HT6 receptor antagonist potentially useful as cognition enhancer

Feb. 25, 2008

New therapeutic agents for neurological disorders reported in recent patents

Feb. 25, 2008

Novel analgesic agents disclosed in recent patent literature

Feb. 25, 2008

Proteomic analysis identifies new potential targets for multiple sclerosis

Feb. 22, 2008

New compounds for treating pain and other inflammatory conditions described in recent patents

Feb. 22, 2008

NeuroHealing initiates phase II clinical trial of NH-004 for sialorrhea in PD patients

Feb. 22, 2008

Memory and Roche to initiate biomarker clinical study of MEM-3454 for schizophrenia

Feb. 20, 2008

Cognitive improvement seen with intranasal insulin in early Alzheimer's disease

Feb. 20, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 29, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...